Dye Ingress For CCIT: A Poor Bet In A High Stakes Game
By Oliver Stauffer

The dye ingress test method continues to be a widely used test method for Container Closure Integrity (CCI) within the pharmaceutical industry. For high risk parenteral applications this method is not a suitable approach due to reliability of the method and measure. For applications with large molecule drugs or for prefilled injectable container formats, the use of a dye ingress test method will simply not work. There is an active campaign to understand all the dynamics and implications of deploying a CCI test method. The transition to a deterministic test method for high risk CCI applications is a matter of common-sense patient safety.
VIEW THE WHITE PAPER!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
PTI Packaging and Inspection Systems
This website uses cookies to ensure you get the best experience on our website. Learn more